A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcadeā¢), in combination with paclitaxel and carboplatin in patients with advanced malignancies
Titel:
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcadeā¢), in combination with paclitaxel and carboplatin in patients with advanced malignancies
Auteur:
Ma, Cynthia Mandrekar, Sumithra J. Alberts, Steven R. Croghan, Gary A. Jatoi, Aminah Reid, Joel M. Hanson, Lorelei J. Bruzek, Laura Tan, Angelina D. Pitot, Henry C. Erlichman, Charles Wright, John J. Adjei, Alex A.